Antibiotics

You have access
Initial studies with FK506 in renal transplantation
Mark L. Jordan, MD, Ron Shapiro, MD, John Fung, MD, PhD, Andreas Tzakis, MD, Saturo Todo, MD, Shimon Kusne, MD, Jake Demetrius, MD, Thomas R. Hakala, MD and Thomas E. Starzl, MD, PhD

Cleveland Clinic Journal of Medicine September 1991, 58 (5) 444-446;

Advantages of this immunosuppressive agent include relatively few side effects and high potency, eliminating the need for steroids in some patients.
You have access
Comparative activity of newer antibiotics against gram-negative bacilli
Cynthia C. Knapp, MS and John A. Washington, MD

Cleveland Clinic Journal of Medicine March 1989, 56 (2) 161-166;
You have access
In vitro comparison of activity of Cefixime with activities of other orally administered antimicrobial agents
Cynthia C. Knapp, MS and John A. Washington, MD

Cleveland Clinic Journal of Medicine September 1988, 55 (5) 477-482;
You have access
Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients
Alfonso Alanis, M.D., Susan Rehm, M.D. and Allan J. Weinstein, M.D.

Cleveland Clinic Journal of Medicine December 1983, 50 (4) 385-395;

Main menu